Skip to main content
ChemoMetec logo

ChemoMetec — Investor Relations & Filings

Ticker · CHEMM ISIN · DK0060055861 LEI · 213800533NBKECGONO68 CO Manufacturing
Open in API
Filings indexed 538 across all filing types
Latest filing 2025-09-11 Annual Report
Country DK Denmark
Listing CO CHEMM

About ChemoMetec

https://chemometec.com

ChemoMetec is a global manufacturer specializing in high-precision automated cell counting and analysis instrumentation. The company develops and produces a range of advanced image cytometers and cell density analyzers, including the NucleoCounter® and XcytoMatic® series. These systems provide consistent, reproducible, and accurate cell count and viability data for a wide range of cell types. Key technologies include fluorescence microscopy, which enables trypan blue-free analysis, and specialized consumables designed to minimize human error. ChemoMetec's instruments are designed for regulated environments, offering software solutions compliant with FDA 21 CFR Part 11 and supporting Good Manufacturing Practice (GMP) workflows. The company serves customers in the biotechnology, pharmaceutical, and academic sectors, with applications in cell and gene therapy, cancer research, and bioprocessing.

Recent filings

Filing Released Lang Actions
Annual Report 2025
Annual Report Classification · 1% confidence The document is explicitly titled 'Annual Report 2024/25' and contains comprehensive sections including a CEO letter, financial highlights, business model, performance review, governance, and consolidated financial statements. It meets the criteria for a full annual report as it covers the company's yearly activity and financial performance. FY 2025
2025-09-11 English
Annual Report (ESEF) 2025
Annual Report (ESEF) Classification · 1% confidence FY 2025
2025-09-11 Danish
Management Reports 2025
Management Reports Classification · 1% confidence The document is a short announcement (1610 characters) titled 'Forventninger til regnskabsåret 2025/26' (Expectations for the 2025/26 financial year). It explicitly states that the annual report for 2024/25 is being published simultaneously with this announcement. According to the 'Menu vs Meal' rule, since this is a short announcement regarding the release of a report, it is classified as a Report Publication Announcement (RPA).
2025-09-11 Danish
Earnings Release 2025
Earnings Release Classification · 1% confidence The document is a short announcement (1671 characters) that provides financial guidance for the 2025/26 fiscal year and explicitly states that the annual report for 2024/25 is released along with this announcement. Per the 'Menu vs Meal' rule, since this is a short announcement regarding the publication of a report, it is classified as a Report Publication Announcement (RPA). FY 2025
2025-09-11 English
Earnings Release 2025
Earnings Release Classification · 1% confidence The document is very short (903 characters) and dated July 1, 2025. It provides preliminary revenue figures for the fiscal year 2024/25 (DKK 496 million vs. previous guidance DKK 470-490 million) and explicitly states when the full annual report is expected to be published ('ChemoMetecs årsrapport for 2024/25 forventes offentliggjort den 11. september 2025'). This structure—providing key preliminary results and announcing the future release date of the main report—is characteristic of an Earnings Release (ER) or a preliminary results announcement, which focuses on key highlights before the comprehensive report is available. Since it is a preliminary announcement of financial results, ER is the most appropriate classification, rather than RPA, which usually announces the publication of a full, already-prepared document. FY 2025
2025-07-01 Danish
Earnings Release 2025
Earnings Release Classification · 1% confidence The document is very short (1578 characters) and is titled "Foreløbige tal for omsætningen i regnskabsåret 2024/25" (Preliminary figures for revenue in the fiscal year 2024/25). It announces preliminary revenue figures and states when the full annual report is expected to be published ("ChemoMetecs årsrapport for 2024/25 forventes offentliggjort den 11. september 2025"). It also includes an attachment link. This structure—a brief announcement about preliminary results and the future publication of a main report—fits the definition of an Earnings Release (ER) or, more precisely, a regulatory announcement regarding financial performance updates. Since it is not the full report (10-K or IR) but an update on key figures, ER is the most appropriate fit among the financial reporting codes. It is not a general regulatory filing (RNS) because it specifically concerns earnings/revenue figures. FY 2025
2025-07-01 Danish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.